• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: THERAKOS, INC. THERAKOS UVAR XTS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

THERAKOS, INC. THERAKOS UVAR XTS Back to Search Results
Model Number 6660
Device Problem Insufficient Information (3190)
Patient Problems Respiratory Distress (2045); No Code Available (3191)
Event Date 12/23/2013
Event Type  malfunction  
Event Description
Customer called to report he suspects drop in hematocrit is due to treatment procedure with uvar xts instrument.Name and function of complainant: therakos field trainer (fts) reported on behalf of customer.Therakos fts emailed cts to report on behalf of customer suspicion of a drop in the hematocrit levels of a pt had been observed over period of multiple treatment.Pt received transfusion on (b)(6) 2013.Started treatments on (b)(6) 2013, hgb 11.9.Next 2 treatments on (b)(6) 2013, hgb 12.1.Next 2 treatments on (b)(6) 2013, hgb 9.8.Pt was symptomatic and was admitted.Complained being light headed and short of breath.Vs stable.He also stated that he ran a temp of 100.3 on (b)(6) 2013 but did not tell anyone.He also received ivig (b)(6) 2013.Customer did not return the kit for investigation.Fts spoke with customer and discussed the need to do a manual return of residual red blood cells following frequent xts ecp treatments in order to maintain hematocrit.Currently they are not doing this.Fts confirmed that customer has the most recent copy of the xts operator's manual (rev j) and that it contains the instructions for manual return of the residual red blood cells (bcs) to maintain hematocrit.Customer stated will try this method with the next treatment procedure.They will call at that time if they need further assistance.
 
Manufacturer Narrative
Batch record review could not be conducted because lot number was not provided.A follow-up attempt was made to obtain a lot number, but cts rep was not able to obtain the info.Complaint lot review could not be conducted since no lot number provided.The assessment is based on info available at the time of the investigation.The instrument performed as intended; however, the therakos has elected to report this incident due to the pt being admitted and transfused.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
THERAKOS UVAR XTS
Type of Device
XTS
Manufacturer (Section D)
THERAKOS, INC.
bridgewater NJ
Manufacturer (Section G)
HARMAC MED PRODUCTS
2201 bailey ave
buffalo NY 14211
Manufacturer Contact
440 us route 22 east, ste 140
bridgewater, NJ 08807
9083675452
MDR Report Key3747945
MDR Text Key4465234
Report Number2523595-2014-00032
Device Sequence Number1
Product Code LNR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P680003
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 12/23/2013
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model Number6660
Device Lot NumberUNKWN KIT
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/23/2013
Initial Date FDA Received01/22/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-